Back to Search
Start Over
Alpha Cognition Receives Notice of Allowance for Composition-of-Matter Patent for ZUNVEYL[R] for Mild to Moderate Alzheimer's Disease
- Source :
- Business Wire. August 19, 2024
- Publication Year :
- 2024
-
Abstract
- VANCOUVER, British Columbia -- Alpha Cognition Inc. (CSE: ACOG) (OTCQB: ACOGF) (Alpha Cognition 'ACI', or the 'Company'), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, is pleased to [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Business Wire
- Publication Type :
- News
- Accession number :
- edsgcl.805305851